Published in Medical Letter on the CDC and FDA, March 6th, 2000
"Approximately 45 million Americans have serologic evidence of HSV-2 infection and HSV-2 seroprevalence has increased 30% over the past two decades," according to G.Y. Tao and colleagues at the U.S. Centers for Disease Control and Prevention ("Medical care expenditures for genital herpes in the United States," Sexually Transmitted Diseases, January 2000;27(1):32-38). Despite the rapid increase in herpes cases, Tao et al. noted that the last cost estimate for genital herpes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.